The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 07, 2019

Filed:

Jul. 23, 2015
Applicant:

Industry-academic Cooperation Foundation, Dankook University, Gyeonggi-do, KR;

Inventors:

Seong Wook Lee, Seoul, KR;

Ju Hyun Kim, Gyeonggi-do, KR;

Jin Sook Jeong, Busan, KR;

Sang Young Han, Busan, KR;

Assignee:

RZNOMICS INC., Gyeonggdi-Do, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); C07H 21/02 (2006.01); C07H 21/04 (2006.01); C12N 15/113 (2010.01); A61K 38/43 (2006.01); A61K 31/713 (2006.01); C12N 15/85 (2006.01); C12N 15/86 (2006.01); C07K 14/47 (2006.01); C12N 9/22 (2006.01); C12N 15/63 (2006.01); C12N 15/79 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C12N 15/113 (2013.01); A61K 31/713 (2013.01); A61K 38/43 (2013.01); A61K 48/0058 (2013.01); A61K 48/0066 (2013.01); C07K 14/4705 (2013.01); C12N 9/22 (2013.01); C12N 15/1135 (2013.01); C12N 15/63 (2013.01); C12N 15/79 (2013.01); C12N 15/85 (2013.01); C12N 15/86 (2013.01); A61K 38/00 (2013.01); C07K 2319/01 (2013.01); C07K 2319/33 (2013.01); C07K 2319/61 (2013.01); C12N 2310/113 (2013.01); C12N 2310/12 (2013.01); C12N 2310/124 (2013.01); C12N 2310/128 (2013.01); C12N 2330/51 (2013.01); C12N 2710/10343 (2013.01); C12N 2830/008 (2013.01); C12N 2830/42 (2013.01); C12N 2830/48 (2013.01);
Abstract

The present invention relates to a recombination vector, a transformation cell into which the recombinant vector is introduced, a ribozyme expressed from the recombination vector, a prophylactic or therapeutic composition for liver cancer comprising the recombination vector and the ribozyme, and a therapeutic method for liver cancer using the composition, said recombination vector comprising: a tissue-specific promoter; and a ribozyme-target gene expression cassette comprising a trans-splicing ribozyme targeting a cancer-specific gene and a target gene connected to the 3' exon of the ribozyme, wherein a splicing donor/splicing acceptor sequence (SD/SA sequence) is connected to the 5′ end of the ribozyme-target gene expression cassette, woodchuck hepatitis virus posttranscriptional regulatory element (WPRE) is connected to the 3′ end of the ribozyme-target gene expression cassette, and a nucleic acid sequence recognizing a micro RNA-122a (microRNA-122a, miR-122a) is further connected to the 3′ end of the WPRE.


Find Patent Forward Citations

Loading…